0001225208-24-001898.txt : 20240212 0001225208-24-001898.hdr.sgml : 20240212 20240212192510 ACCESSION NUMBER: 0001225208-24-001898 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240208 FILED AS OF DATE: 20240212 DATE AS OF CHANGE: 20240212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wolk Joseph J CENTRAL INDEX KEY: 0001744564 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 24622071 MAIL ADDRESS: STREET 1: JOHNSON & JOHNSON STREET 2: ONE JOHNSON & JOHNSON PLAZA CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 4 1 doc4.xml X0508 4 2024-02-08 0000200406 JOHNSON & JOHNSON JNJ 0001744564 Wolk Joseph J ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 1 Exec VP, CFO 0 Common Stock 2024-02-08 4 M 0 3686.0000 0.0000 A 53911.0000 D Common Stock 2024-02-08 4 F 0 1047.0000 156.3300 D 52864.0000 D Common Stock 2048.0000 I By 401k Restricted Share Units 2024-02-08 4 M 0 3686.0000 0.0000 D 2024-02-08 Common Stock 3686.0000 0.0000 D Restricted Share Units awarded under Long-Term Incentive Plan on February 8, 2021 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting. Shares withheld for payment of taxes upon vesting of Restricted Share Units. Reflects an adjustment to the total number of shares previously reported by the reporting person after a reconciliation of such person's ownership records. Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2024). /s/ Raavi K. Deol, as attorney-in-fact for Joseph J. Wolk 2024-02-12